SeQuent Scientific Ltd

Ticker: SEQUENT
Decent 68/100

☆ Add to Watchlist

Investing Reference

Price
213.32
Market Cap
5361.81
Debt/Equity
0.6247
ROE %
2.949
PB
6.9601
Promoter %
52.608
Pledge %
0.000
1Y Rev Growth %
12.533
5Y Rev Growth %
5.715
NP Margin %
1.393
NP Margin 5Y Avg %
0.036

Trading Reference

1M Return %
14.203
6M Return %
48.026
1Y Return %
8.637
% Away 52W High
8.288
% Away 52W Low
81.781
Daily Volume
731603
Investment Verdict
Avoid
Score 40/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Momentum
Score 71/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

SeQuent Scientific Ltd is currently trading near a key support level, with recent price action showing bullish momentum as it approaches the 50-day EMA. If it breaks above the resistance at INR 250, there is potential for upward movement towards INR 280. However, if it falls below the support at INR 220, it could decline towards INR 200.
Upside Probability: 12%   |   Downside Probability: 9.1%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

SeQuent Scientific Ltd is a leading player in the Indian pharmaceutical and animal health sectors, specializing in the development and manufacturing of high-quality products. Catering to a diverse clientele, including healthcare providers and veterinary professionals, SeQuent is committed to enhancing health and well-being across communities. With a strong focus on innovation and sustainability, the company plays a crucial role in addressing the growing demand for effective healthcare solutions. Its robust R&D capabilities and strategic partnerships position it as a trusted leader in the industry.

  • Leading pharmaceutical and animal health company
  • Focus on innovation and sustainability
  • Strong R&D capabilities
  • Diverse clientele across healthcare sectors
  • Committed to enhancing community health

Investment Thesis

SeQuent Scientific Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's strategic focus on innovation and expansion positions it well for future growth, making it a noteworthy addition to any portfolio.

  • Strong promoter group with a proven track record in the pharmaceutical sector.
  • Significant growth potential in digital services, tapping into evolving market demands.
  • Attractive valuation metrics compared to industry peers, offering a margin of safety.
  • Focus on innovation and R&D, enhancing competitive advantage.
  • Positive industry outlook, driven by increasing global healthcare needs.

Opportunity vs Risk

Opportunities
  • Growing demand for animal health products
  • Expansion into new international markets
  • Strong R&D capabilities
  • Strategic partnerships with key players
Risks ⚠️
  • Regulatory changes impacting operations
  • Intense competition in the sector
  • Dependence on a few major clients
  • Fluctuating raw material costs

Peer Perspective

SeQuent Scientific Ltd trades at a discount to peers like Syngene and Divi's Laboratories, reflecting concerns over margin stability. A consistent improvement in operational efficiencies could trigger a rerating in its valuation.

AI FAQs for Retail Users

  • Q: What does SeQuent Scientific Ltd do?
    A: SeQuent Scientific Ltd is a leading global player in the animal health and pharmaceutical sectors.
  • Q: Is SeQuent Scientific Ltd a good investment?
    A: Investing in stocks depends on individual financial goals and risk appetite. Research thoroughly before making decisions.
  • Q: What are the recent developments for SeQuent Scientific Ltd?
    A: Recent developments include product launches and expansions in international markets, enhancing their growth prospects.
  • Q: How can I buy shares of SeQuent Scientific Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: What are the risks associated with investing in SeQuent Scientific Ltd?
    A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical industry.
📊 Stock Investment Checklist (100 Points)
SeQuent Scientific Ltd • Updated: 2025-09-18 00:55:53
  • 10
    Business
    High
    The sector is growing with increasing demand for animal health products, but competition is high.
  • 10
    Growth
    High
    Revenue growth has been consistent, but profit margins are under pressure.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF is fluctuating.
  • 8
    Valuation
    High
    Valuation metrics are slightly above industry averages.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity could be improved.
  • 6
    Governance
    Good
    Promoter holding is stable, but there are some concerns regarding disclosures.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks remain.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100 • Decent
SeQuent Scientific Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 75/100
  • Profitability: 65/100
  • Governance: 60/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.